SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,637.37 (-2.86%)
DOW   29,247.88 (-2.27%)
QQQ   269.09 (-3.81%)
AAPL   140.08 (-3.68%)
MSFT   234.14 (-5.13%)
META   132.99 (-4.37%)
GOOGL   98.46 (-2.92%)
AMZN   114.60 (-4.74%)
TSLA   223.02 (-6.35%)
NVDA   121.25 (-7.65%)
NIO   13.70 (-7.24%)
BABA   80.90 (-4.06%)
AMD   59.22 (-12.72%)
T   15.02 (-1.96%)
MU   53.03 (-2.91%)
CGC   2.80 (-25.33%)
F   12.14 (-1.78%)
GE   64.19 (-3.07%)
DIS   96.67 (-3.37%)
AMC   6.46 (-9.27%)
PYPL   89.97 (-4.71%)
PFE   42.14 (-2.20%)
NFLX   227.67 (-5.15%)
S&P 500   3,637.37 (-2.86%)
DOW   29,247.88 (-2.27%)
QQQ   269.09 (-3.81%)
AAPL   140.08 (-3.68%)
MSFT   234.14 (-5.13%)
META   132.99 (-4.37%)
GOOGL   98.46 (-2.92%)
AMZN   114.60 (-4.74%)
TSLA   223.02 (-6.35%)
NVDA   121.25 (-7.65%)
NIO   13.70 (-7.24%)
BABA   80.90 (-4.06%)
AMD   59.22 (-12.72%)
T   15.02 (-1.96%)
MU   53.03 (-2.91%)
CGC   2.80 (-25.33%)
F   12.14 (-1.78%)
GE   64.19 (-3.07%)
DIS   96.67 (-3.37%)
AMC   6.46 (-9.27%)
PYPL   89.97 (-4.71%)
PFE   42.14 (-2.20%)
NFLX   227.67 (-5.15%)
S&P 500   3,637.37 (-2.86%)
DOW   29,247.88 (-2.27%)
QQQ   269.09 (-3.81%)
AAPL   140.08 (-3.68%)
MSFT   234.14 (-5.13%)
META   132.99 (-4.37%)
GOOGL   98.46 (-2.92%)
AMZN   114.60 (-4.74%)
TSLA   223.02 (-6.35%)
NVDA   121.25 (-7.65%)
NIO   13.70 (-7.24%)
BABA   80.90 (-4.06%)
AMD   59.22 (-12.72%)
T   15.02 (-1.96%)
MU   53.03 (-2.91%)
CGC   2.80 (-25.33%)
F   12.14 (-1.78%)
GE   64.19 (-3.07%)
DIS   96.67 (-3.37%)
AMC   6.46 (-9.27%)
PYPL   89.97 (-4.71%)
PFE   42.14 (-2.20%)
NFLX   227.67 (-5.15%)
S&P 500   3,637.37 (-2.86%)
DOW   29,247.88 (-2.27%)
QQQ   269.09 (-3.81%)
AAPL   140.08 (-3.68%)
MSFT   234.14 (-5.13%)
META   132.99 (-4.37%)
GOOGL   98.46 (-2.92%)
AMZN   114.60 (-4.74%)
TSLA   223.02 (-6.35%)
NVDA   121.25 (-7.65%)
NIO   13.70 (-7.24%)
BABA   80.90 (-4.06%)
AMD   59.22 (-12.72%)
T   15.02 (-1.96%)
MU   53.03 (-2.91%)
CGC   2.80 (-25.33%)
F   12.14 (-1.78%)
GE   64.19 (-3.07%)
DIS   96.67 (-3.37%)
AMC   6.46 (-9.27%)
PYPL   89.97 (-4.71%)
PFE   42.14 (-2.20%)
NFLX   227.67 (-5.15%)
NYSE:USPH

U.S. Physical Therapy - USPH Stock Forecast, Price & News

$78.73
-0.75 (-0.94%)
(As of 10/7/2022 02:00 PM ET)
Add
Compare
Today's Range
$78.49
$79.69
50-Day Range
$74.54
$130.18
52-Week Range
$73.30
$131.50
Volume
1,052 shs
Average Volume
82,710 shs
Market Capitalization
$1.02 billion
P/E Ratio
26.87
Dividend Yield
2.04%
Price Target
$121.50

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
54.3% Upside
$121.50 Price Target
Short Interest
Bearish
4.46% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.23mentions of U.S. Physical Therapy in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$918,170 Sold Last Quarter
Proj. Earnings Growth
11.11%
From $2.70 to $3.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Medical Sector

61st out of 1,075 stocks

Health Services Industry

1st out of 12 stocks

USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

USPH U.S. Physical Therapy, Inc.
Let IV therapy in Charleston come to you
US Physical Therapy Inc
U.S. Physical Therapy, Inc.
U.S. Physical Therapy: All Is Not Over, Hold For Now
U.S. Physical Therapy: Outpatient Pure Play
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Company Calendar

Last Earnings
8/04/2022
Ex-Dividend for 9/16 Dividend
8/17/2022
Dividend Payable
9/16/2022
Today
10/07/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
5,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$121.50
High Stock Price Forecast
$123.00
Low Stock Price Forecast
$120.00
Forecasted Upside/Downside
+54.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$40.83 million
Pretax Margin
13.50%

Debt

Sales & Book Value

Annual Sales
$495.02 million
Cash Flow
$4.72 per share
Book Value
$23.02 per share

Miscellaneous

Free Float
12,757,000
Market Cap
$1.02 billion
Optionable
Optionable
Beta
1.29

Key Executives

  • Mr. Christopher J. ReadingMr. Christopher J. Reading (Age 58)
    Pres, CEO & Director
    Comp: $2.02M
  • Mr. Carey P. Hendrickson (Age 60)
    Chief Financial Officer
    Comp: $902.32k
  • Mr. Graham D. Reeve M.B.A.Mr. Graham D. Reeve M.B.A. (Age 58)
    P.T., Chief Operating Officer - West
    Comp: $1.28M
  • Mr. Eric Joseph Williams (Age 56)
    Chief Operating Officer - East
    Comp: $648.2k
  • Mr. Jake Martinez (Age 43)
    Sr. VP of Fin. & Accounting
  • Mr. Chadd Pence
    Sr. VP of Information Systems
  • Mr. Richard S. Binstein (Age 61)
    Exec. VP, Gen. Counsel & Sec.
  • Ms. Jayne Fleck Pool ATC
    PT, SCS, Sr. VP & Chief Compliance Officer
  • Mr. Jason Anderson
    VP of HR
  • Mr. Jon C. Bates (Age 52)
    VP & Corp. Controller













USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2022?

2 brokerages have issued 1 year target prices for U.S. Physical Therapy's shares. Their USPH share price forecasts range from $120.00 to $123.00. On average, they predict the company's share price to reach $121.50 in the next year. This suggests a possible upside of 52.9% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2022?

U.S. Physical Therapy's stock was trading at $95.55 at the start of the year. Since then, USPH stock has decreased by 16.8% and is now trading at $79.48.
View the best growth stocks for 2022 here
.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a decline in short interest in August. As of August 31st, there was short interest totaling 561,800 shares, a decline of 18.7% from the August 15th total of 691,400 shares. Based on an average daily volume of 94,500 shares, the days-to-cover ratio is currently 5.9 days. Approximately 4.4% of the shares of the stock are short sold.
View U.S. Physical Therapy's Short Interest
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings data on Thursday, August, 4th. The company reported $0.90 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.93 by $0.03. The business earned $140.70 million during the quarter, compared to the consensus estimate of $143.01 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 14.22% and a net margin of 7.62%. U.S. Physical Therapy's revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.96 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, August 4th. Shareholders of record on Thursday, August 18th will be paid a dividend of $0.41 per share on Friday, September 16th. This represents a $1.64 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Wednesday, August 17th.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 2.04%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 55.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 54.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY 2022 earnings guidance on Thursday, August, 25th. The company provided earnings per share guidance of $2.65-$2.75 for the period. The company issued revenue guidance of -.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $79.48.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.03 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.93 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 5,500 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.